Skip to content

Data acquisition and accuracy confirmation test for device measurements, fingertip blood glucose levels, and venous blood glucose levels

Data acquisition and accuracy confirmation test for device measurements, fingertip blood glucose levels, and venous blood glucose levels - Data acquisition and accuracy confirmation test for device measurements, fingertip blood glucose levels, and venous blood glucose levels

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060136
Enrollment
65
Registered
2025-12-22
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Suntory Global Innovation Center Ltd.
Lead Sponsor
Oneness Support
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy male and female whose ages are 20 to <65 years old. (2) Individuals who have undergone a health checkup or comprehensive medical examination within the past 12 months (3) Subjects who agree with the given description and express informed consent via telecommunication and written documents.

Exclusion criteria

Exclusion criteria: 1.Systolic pressure <90 mmHg 2.pregnant or lactating. 3.Individuals with a fasting blood glucose level of 126 mg/dL or higher in their most recent health checkup or comprehensive medical examination 4.Individuals whose BMI was less than 18.5 kg/m2 or 30.0 kg/m2 or higher in their most recent health checkup or comprehensive medical examination 5.Individuals whose HbA1c (hemoglobin A1c) level was 6.5% or higher in their most recent health checkup or comprehensive medical examination 6.Subjects who donated over 200ml blood components or whole blood within the past 4 weeks prior to the current study. 7.Male Subjects who donated over 400ml whole blood within the past 12 weeks prior to the current study. 8.Female who donated over 400ml whole blood within the past 16 weeks prior to the current study. 9.Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 10.Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 11.participating in other clinical studies, or who finished clinical study within the last 4 weeks. 12a.disease on heart, liver, kidney or other organs complications. 12b.a previous history of disease on circulatory organs. 12c.diabetes. 13.gastrointestinal diseases and/or a history of surgery affecting digestion and absorption 14.alcohol sensitivity 15.a previous history of feeling sick after blood sampling. 16.metal and/or latex allergic contact dermatitis 17.allergies to glucose tolerance. 18.have had an abnormal ECG (arrhythmia) indicated in the past. 19.are constantly taking certain drug medicine, 20.drink alcohol a lot 21.work irregular shifts or at midnight. 22.judged as unsuitable for the study by the principal investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Accuracy of device measurements compared to reference blood glucose values

Countries

Japan

Contacts

Public ContactNaoyuki Matsuzaki

Suntory Global Innovation Center Ltd. Novel Business Development Department

Naoyuki_Matsuzaki@suntory.co.jp050-1804-0215

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026